Homology Medicines, Inc. (FIXX)’in fiyatı nedir?

Homology Medicines, Inc. (FIXX)’in fiyatı $0.9347’dir

Homology Medicines, Inc. (FIXX)’in piyasa değeri nedir?

Homology Medicines, Inc. (FIXX)’in piyasa değeri $300.42K’dir.

Homology Medicines, Inc. (FIXX) F/S Oranı

Homology Medicines, Inc. is a biotechnology firm dedicated to genetic therapeutics, striving to enhance the well-being of patients battling rare inherited disorders. The company leverages its unique platform, which employs adeno-associated virus vectors (AAVHSCs) originating from human hematopoietic stem cells, to introduce genetic treatments directly into the body. This approach facilitates either gene therapy or nuclease-free gene editing solutions for a range of genetic ailments. Crucially, Homology's diverse collection of AAVHSCs enables the precise targeting of multiple disease-affected tissues—such as the liver, central and peripheral nervous systems, bone marrow, heart, skeletal muscles, and eyes—all from a single administration. The leading candidate in their pipeline, HMI-102, is a gene therapy undergoing the Phase 2 pheNIX clinical trial, intended for adult patients with phenylketonuria (PKU). Beyond this, their development portfolio includes HMI-103 for pediatric PKU, HMI-202 targeting metachromatic leukodystrophy, HMI-203 for mucopolysaccharidosis type II, and HMI-104 designed to address paroxysmal nocturnal hemoglobinuria. Established in 2015, Homology Medicines, Inc. maintains its corporate headquarters in Bedford, Massachusetts.

Yıl	P/S Oranı	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

P/S Oranı

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	P/S Oranı	P/S Oranı Farkı	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	9.88	-	US
Argenx SE ARGX.US	10.30	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	4.98	-	BE

Şirket

P/S Oranı

P/S Oranı Farkı

Ülke